President & Representative Director, Kohjin Bio Co., Ltd.
Other assets (est.): the sum of each year's after-tax income (pay + dividends in own name − estimated taxes and social insurance) dividends retained by asset-management companies (less about 20% corporate tax), and proceeds from share sales (the drop in shares from the previous year × share price, less 20.315% tax, or about 30% for asset-management companies), for the years we have data. Spending, real estate, donations and savings from earlier years are not reflected.
Asset-management companies: TAKAコーポレーションest., TAKAコーポレーション株式会社est. (their holdings are included in net worth)
| Company | Held by | Shares | Stake | Price | Value | Dividends |
|---|---|---|---|---|---|---|
| Kohjin Bio Co., Ltd. 177A · FY ending Mar 2026 · President & Representative Director |
Own name | 2,209,500 | 43.20% | ¥1,208 | ¥2.7B | ¥22.1M |
| Kohjin Bio Co., Ltd. 177A · FY ending Mar 2026 |
TAKAコーポレーション株式会社 | 416,500 | 8.20% | ¥1,208 | ¥503M | ¥4.2M |
| Year | Net worth | Pay | Dividends | Total income | Taxes (est.) | After tax (est.) | Share sales (after tax) |
|---|---|---|---|---|---|---|---|
| 2026 | ¥3.2B | ¥32.7M | ¥26.3M | ¥58.9M | ¥22.1M | ¥30.7M | — |
| 2025 | ¥4.6B | ¥29.2M | ¥63.0M | ¥92.3M | ¥35.5M | ¥44.8M | — |
| 2024 | ¥4.6B | ¥33.8M | ¥36.8M | ¥70.5M | ¥27.1M | ¥35.6M | — |
Grouped by the calendar year of each company's fiscal year-end. Years in which the person was not among the top 10 shareholders of a company exclude that company.